These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35937821)

  • 1. REG1A and RUNX3 Are Potential Biomarkers for Predicting the Risk of Diabetic Kidney Disease.
    Wang X; Wu H; Yang G; Xiang J; Xiong L; Zhao L; Liao T; Zhao X; Kang L; Yang S; Liang Z
    Front Endocrinol (Lausanne); 2022; 13():935796. PubMed ID: 35937821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into serum metabolic biomarkers for early detection of incident diabetic kidney disease in Chinese patients with type 2 diabetes by random forest.
    Jiang JJ; Sham TT; Gu XF; Chan CO; Dong NP; Lim WH; Song GF; Li SM; Mok DK; Ge N
    Aging (Albany NY); 2024 Feb; 16(4):3420-3530. PubMed ID: 38349886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting diagnostic gene biomarkers in patients with diabetic kidney disease based on weighted gene co expression network analysis and machine learning algorithms.
    Gao Q; Jin H; Xu W; Wang Y
    Medicine (Baltimore); 2023 Oct; 102(43):e35618. PubMed ID: 37904449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
    Huang B; Wen W; Ye S
    Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of diagnostic gene biomarkers and immune infiltration in patients with diabetic kidney disease using machine learning strategies and bioinformatic analysis.
    Fu S; Cheng Y; Wang X; Huang J; Su S; Wu H; Yu J; Xu Z
    Front Med (Lausanne); 2022; 9():918657. PubMed ID: 36250071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
    BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study.
    Liu XZ; Duan M; Huang HD; Zhang Y; Xiang TY; Niu WC; Zhou B; Wang HL; Zhang TT
    Front Endocrinol (Lausanne); 2023; 14():1184190. PubMed ID: 37469989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
    Ren X; Wang W; Cao H; Shao F
    Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and External Validation of Machine Learning Models for Diabetic Microvascular Complications: Cross-Sectional Study With Metabolites.
    He F; Ng Yin Ling C; Nusinovici S; Cheng CY; Wong TY; Li J; Sabanayagam C
    J Med Internet Res; 2024 Mar; 26():e41065. PubMed ID: 38546730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathophysiologic Mechanisms and Potential Biomarkers in Diabetic Kidney Disease.
    Jung CY; Yoo TH
    Diabetes Metab J; 2022 Mar; 46(2):181-197. PubMed ID: 35385633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum level of pancreatic stone protein/regenerating protein (PSP/reg) is observed in diabetic kidney disease.
    Li L; Jia D; Graf R; Yang J
    Oncotarget; 2017 Jun; 8(24):38145-38151. PubMed ID: 28418911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Expression Level of LncRNA Malat1 in Diabetic Kidney Disease Patients and Its Clinical Significance.
    Zhou LJ; Yang DW; Ou LN; Guo XR; Wu BL
    J Diabetes Res; 2020; 2020():4729019. PubMed ID: 32832561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research status and prospect of novel biomarkers for diabetic kidney disease].
    Feng ST; Wang B; Liu BC
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):691-694. PubMed ID: 33721945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.